Evaluation of a reduced nicotine product standard

Moderating effects of and impact on cannabis use

Lauren R. Pacek, Ryan Vandrey, Sarah S. Dermody, Rachel L. Denlinger-Apte, Andrine Lemieux, Jennifer W. Tidey, F. Joseph McClernon, Ananta S Bangdiwala, David J. Drobes, Mustafa N al'Absi, Andrew A. Strasser, Joe Koopmeiners, Dorothy K Hatsukami, Eric C. Donny

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction The Family Smoking Prevention and Tobacco Control Act authorized the FDA to reduce the nicotine content in cigarettes. Research is needed to guide proposed regulations, including evaluation of consequences to public health. This study evaluated how a reduced nicotine product standard might be moderated by and impact cannabis use. Methods Secondary analysis of a controlled clinical trial examining the effects of nicotine content in cigarettes in adult daily smokers. Linear regression assessed whether baseline cannabis use moderated behavioral, subjective, or physiological effects of smoking very low nicotine content (VLNC) versus normal nicotine content (NNC) cigarettes. Repeated measures analysis of associations between nicotine condition and prevalence and frequency of cannabis use was completed using generalized estimating equations (GEE). Results Cannabis use did not moderate most of the following effects of VLNC cigarettes: Among cannabis users and non-users, smokers randomized to VLNC cigarettes reported lower nicotine dependence, cigarettes per day, biomarkers of nicotine exposure, and craving compared to smokers randomized to NNC cigarettes. Non-cannabis using smokers randomized to VLNC cigarettes also reported lower smoking dependence motives and had lower tobacco-specific nitrosamine exposure and total puff volume versus smokers randomized to NNC cigarettes. For cannabis users, smokers randomized to VLNC cigarettes reported decreased positive affect. VLNC cigarette use did not impact the prevalence or frequency of cannabis use. Discussion Findings provide evidence that nicotine reduction in cigarettes could have beneficial effects on cigarette smoking regardless of cannabis use. Results suggest that transitioning to VLNC cigarettes is unlikely to alter current rates of cannabis use.

Original languageEnglish (US)
Pages (from-to)228-232
Number of pages5
JournalDrug and Alcohol Dependence
Volume167
DOIs
StatePublished - Jan 1 2016

Fingerprint

Cannabis
Nicotine
Tobacco Products
Smoking
Tobacco
Nitrosamines
Tobacco Use Disorder
Controlled Clinical Trials
Biomarkers
Public health
Linear regression
Linear Models

Keywords

  • Cannabis
  • Cigarette
  • Co-use
  • Comorbidity
  • Marijuana
  • Nicotine
  • Smoking

Cite this

Evaluation of a reduced nicotine product standard : Moderating effects of and impact on cannabis use. / Pacek, Lauren R.; Vandrey, Ryan; Dermody, Sarah S.; Denlinger-Apte, Rachel L.; Lemieux, Andrine; Tidey, Jennifer W.; McClernon, F. Joseph; Bangdiwala, Ananta S; Drobes, David J.; al'Absi, Mustafa N; Strasser, Andrew A.; Koopmeiners, Joe; Hatsukami, Dorothy K; Donny, Eric C.

In: Drug and Alcohol Dependence, Vol. 167, 01.01.2016, p. 228-232.

Research output: Contribution to journalArticle

Pacek, Lauren R. ; Vandrey, Ryan ; Dermody, Sarah S. ; Denlinger-Apte, Rachel L. ; Lemieux, Andrine ; Tidey, Jennifer W. ; McClernon, F. Joseph ; Bangdiwala, Ananta S ; Drobes, David J. ; al'Absi, Mustafa N ; Strasser, Andrew A. ; Koopmeiners, Joe ; Hatsukami, Dorothy K ; Donny, Eric C. / Evaluation of a reduced nicotine product standard : Moderating effects of and impact on cannabis use. In: Drug and Alcohol Dependence. 2016 ; Vol. 167. pp. 228-232.
@article{02c1637674f34135bf58684fb55d325b,
title = "Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use",
abstract = "Introduction The Family Smoking Prevention and Tobacco Control Act authorized the FDA to reduce the nicotine content in cigarettes. Research is needed to guide proposed regulations, including evaluation of consequences to public health. This study evaluated how a reduced nicotine product standard might be moderated by and impact cannabis use. Methods Secondary analysis of a controlled clinical trial examining the effects of nicotine content in cigarettes in adult daily smokers. Linear regression assessed whether baseline cannabis use moderated behavioral, subjective, or physiological effects of smoking very low nicotine content (VLNC) versus normal nicotine content (NNC) cigarettes. Repeated measures analysis of associations between nicotine condition and prevalence and frequency of cannabis use was completed using generalized estimating equations (GEE). Results Cannabis use did not moderate most of the following effects of VLNC cigarettes: Among cannabis users and non-users, smokers randomized to VLNC cigarettes reported lower nicotine dependence, cigarettes per day, biomarkers of nicotine exposure, and craving compared to smokers randomized to NNC cigarettes. Non-cannabis using smokers randomized to VLNC cigarettes also reported lower smoking dependence motives and had lower tobacco-specific nitrosamine exposure and total puff volume versus smokers randomized to NNC cigarettes. For cannabis users, smokers randomized to VLNC cigarettes reported decreased positive affect. VLNC cigarette use did not impact the prevalence or frequency of cannabis use. Discussion Findings provide evidence that nicotine reduction in cigarettes could have beneficial effects on cigarette smoking regardless of cannabis use. Results suggest that transitioning to VLNC cigarettes is unlikely to alter current rates of cannabis use.",
keywords = "Cannabis, Cigarette, Co-use, Comorbidity, Marijuana, Nicotine, Smoking",
author = "Pacek, {Lauren R.} and Ryan Vandrey and Dermody, {Sarah S.} and Denlinger-Apte, {Rachel L.} and Andrine Lemieux and Tidey, {Jennifer W.} and McClernon, {F. Joseph} and Bangdiwala, {Ananta S} and Drobes, {David J.} and al'Absi, {Mustafa N} and Strasser, {Andrew A.} and Joe Koopmeiners and Hatsukami, {Dorothy K} and Donny, {Eric C.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.drugalcdep.2016.08.620",
language = "English (US)",
volume = "167",
pages = "228--232",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Evaluation of a reduced nicotine product standard

T2 - Moderating effects of and impact on cannabis use

AU - Pacek, Lauren R.

AU - Vandrey, Ryan

AU - Dermody, Sarah S.

AU - Denlinger-Apte, Rachel L.

AU - Lemieux, Andrine

AU - Tidey, Jennifer W.

AU - McClernon, F. Joseph

AU - Bangdiwala, Ananta S

AU - Drobes, David J.

AU - al'Absi, Mustafa N

AU - Strasser, Andrew A.

AU - Koopmeiners, Joe

AU - Hatsukami, Dorothy K

AU - Donny, Eric C.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Introduction The Family Smoking Prevention and Tobacco Control Act authorized the FDA to reduce the nicotine content in cigarettes. Research is needed to guide proposed regulations, including evaluation of consequences to public health. This study evaluated how a reduced nicotine product standard might be moderated by and impact cannabis use. Methods Secondary analysis of a controlled clinical trial examining the effects of nicotine content in cigarettes in adult daily smokers. Linear regression assessed whether baseline cannabis use moderated behavioral, subjective, or physiological effects of smoking very low nicotine content (VLNC) versus normal nicotine content (NNC) cigarettes. Repeated measures analysis of associations between nicotine condition and prevalence and frequency of cannabis use was completed using generalized estimating equations (GEE). Results Cannabis use did not moderate most of the following effects of VLNC cigarettes: Among cannabis users and non-users, smokers randomized to VLNC cigarettes reported lower nicotine dependence, cigarettes per day, biomarkers of nicotine exposure, and craving compared to smokers randomized to NNC cigarettes. Non-cannabis using smokers randomized to VLNC cigarettes also reported lower smoking dependence motives and had lower tobacco-specific nitrosamine exposure and total puff volume versus smokers randomized to NNC cigarettes. For cannabis users, smokers randomized to VLNC cigarettes reported decreased positive affect. VLNC cigarette use did not impact the prevalence or frequency of cannabis use. Discussion Findings provide evidence that nicotine reduction in cigarettes could have beneficial effects on cigarette smoking regardless of cannabis use. Results suggest that transitioning to VLNC cigarettes is unlikely to alter current rates of cannabis use.

AB - Introduction The Family Smoking Prevention and Tobacco Control Act authorized the FDA to reduce the nicotine content in cigarettes. Research is needed to guide proposed regulations, including evaluation of consequences to public health. This study evaluated how a reduced nicotine product standard might be moderated by and impact cannabis use. Methods Secondary analysis of a controlled clinical trial examining the effects of nicotine content in cigarettes in adult daily smokers. Linear regression assessed whether baseline cannabis use moderated behavioral, subjective, or physiological effects of smoking very low nicotine content (VLNC) versus normal nicotine content (NNC) cigarettes. Repeated measures analysis of associations between nicotine condition and prevalence and frequency of cannabis use was completed using generalized estimating equations (GEE). Results Cannabis use did not moderate most of the following effects of VLNC cigarettes: Among cannabis users and non-users, smokers randomized to VLNC cigarettes reported lower nicotine dependence, cigarettes per day, biomarkers of nicotine exposure, and craving compared to smokers randomized to NNC cigarettes. Non-cannabis using smokers randomized to VLNC cigarettes also reported lower smoking dependence motives and had lower tobacco-specific nitrosamine exposure and total puff volume versus smokers randomized to NNC cigarettes. For cannabis users, smokers randomized to VLNC cigarettes reported decreased positive affect. VLNC cigarette use did not impact the prevalence or frequency of cannabis use. Discussion Findings provide evidence that nicotine reduction in cigarettes could have beneficial effects on cigarette smoking regardless of cannabis use. Results suggest that transitioning to VLNC cigarettes is unlikely to alter current rates of cannabis use.

KW - Cannabis

KW - Cigarette

KW - Co-use

KW - Comorbidity

KW - Marijuana

KW - Nicotine

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=85002920586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002920586&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2016.08.620

DO - 10.1016/j.drugalcdep.2016.08.620

M3 - Article

VL - 167

SP - 228

EP - 232

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

ER -